AT360517B - Verfahren zur herstellung neuer basisch substi- tuierter o-(2-hydroxypropyl)-aldoxime - Google Patents

Verfahren zur herstellung neuer basisch substi- tuierter o-(2-hydroxypropyl)-aldoxime

Info

Publication number
AT360517B
AT360517B AT794377A AT794377A AT360517B AT 360517 B AT360517 B AT 360517B AT 794377 A AT794377 A AT 794377A AT 794377 A AT794377 A AT 794377A AT 360517 B AT360517 B AT 360517B
Authority
AT
Austria
Prior art keywords
aldoxime
hydroxypropyl
producing new
basicly
substituted
Prior art date
Application number
AT794377A
Other languages
English (en)
Other versions
ATA794377A (de
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Priority to AT111480A priority Critical patent/AT360984B/de
Priority to AT111380A priority patent/AT360983B/de
Publication of ATA794377A publication Critical patent/ATA794377A/de
Application granted granted Critical
Publication of AT360517B publication Critical patent/AT360517B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
    • C07D307/73—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by amino or imino, or substituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT794377A 1976-11-09 1977-11-07 Verfahren zur herstellung neuer basisch substi- tuierter o-(2-hydroxypropyl)-aldoxime AT360517B (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT111480A AT360984B (de) 1976-11-09 1980-02-28 Verfahren zur herstellung neuer basisch substi- tuierter 0-(2-hydroxypropyl)-aldoxime
AT111380A AT360983B (de) 1976-11-09 1980-02-28 Verfahren zur herstellung neuer basisch substituierter 0-(2-hydroxypropyl)-aldoxime

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762651084 DE2651084A1 (de) 1976-11-09 1976-11-09 Basisch substituirte o-(2-hydroxypropyl) -aldoxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ATA794377A ATA794377A (de) 1980-06-15
AT360517B true AT360517B (de) 1981-01-12

Family

ID=5992723

Family Applications (1)

Application Number Title Priority Date Filing Date
AT794377A AT360517B (de) 1976-11-09 1977-11-07 Verfahren zur herstellung neuer basisch substi- tuierter o-(2-hydroxypropyl)-aldoxime

Country Status (11)

Country Link
US (1) US4235899A (de)
JP (1) JPS5359660A (de)
AT (1) AT360517B (de)
BE (1) BE860615A (de)
CA (1) CA1117526A (de)
DE (1) DE2651084A1 (de)
DK (1) DK496777A (de)
ES (1) ES463797A1 (de)
FR (1) FR2370045A1 (de)
GB (1) GB1540029A (de)
NL (1) NL7712292A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651083A1 (de) * 1976-11-09 1978-05-18 Hoechst Ag Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
EP0106284B1 (de) * 1982-10-11 1987-06-16 Hoechst Aktiengesellschaft 3-Aryl-7-chlor-3,4-dihydro-acridin-1,9-(2H,10H)-dion-1-oxime und -1-hydrazonderivate, deren Salze, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung
DE3704604A1 (de) * 1987-02-13 1988-08-25 Mack Chem Pharm Oximether von 2,6-dioxabicyclo(3.3.0)octanonen, herstellungsverfahren und anwendung als arzneimittel
EP3010345A4 (de) * 2013-06-21 2017-04-12 The Regents of The University of California Erweitertes therapeutisches potential in antimikrobiellen nitroheteroaryl-mitteln

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184452A (en) * 1965-05-18 New aminoalkoxy compounds and process for theik manufacture
US3836528A (en) * 1968-07-23 1974-09-17 Dainippon Pharmaceutical Co Alpha-(5-nitro-2-furyl)nitrones
US3583985A (en) * 1969-04-09 1971-06-08 Richardson Merrell Inc Nitroimidazolyl nitrones
DE2311177A1 (de) * 1973-03-07 1974-09-19 Hoechst Ag O-(dialkylaminoalkyl)-1-alkyl-5nitroimidazol-(2)-aldoxime und verfahren zu ihrer herstellung
DE2439629B2 (de) * 1974-08-19 1977-06-02 O-dialkylaminoalkyl-5-nitro-2- furanaldoxime, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
FR2370045A1 (fr) 1978-06-02
JPS5359660A (en) 1978-05-29
ATA794377A (de) 1980-06-15
GB1540029A (en) 1979-02-07
CA1117526A (en) 1982-02-02
BE860615A (fr) 1978-05-08
DK496777A (da) 1978-05-10
US4235899A (en) 1980-11-25
DE2651084A1 (de) 1978-12-14
NL7712292A (nl) 1978-05-11
ES463797A1 (es) 1979-09-01

Similar Documents

Publication Publication Date Title
AT366361B (de) Verfahren zur herstellung neuer 2-aminotetraline
AT362363B (de) Verfahren zur herstellung neuer azetidinole
AT371139B (de) Verfahren zur herstellung neuer bitumenzusammen- setzungen
AT351510B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT373251B (de) Verfahren zur herstellung neuer d-6-n-propylergoline
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA246780A (de) Verfahren zur herstellung neuer pyrazinobenzodiazepine
DD133949A5 (de) Verfahren zur herstellung neuer benzopyranderivate
DD132438A5 (de) Verfahren zur herstellung neuer kortikoide
AT355036B (de) Verfahren zur herstellung neuer 1,2,6- thiadiazin-4-one
AT360517B (de) Verfahren zur herstellung neuer basisch substi- tuierter o-(2-hydroxypropyl)-aldoxime
AT367421B (de) Verfahren zur herstellung neuer 1,2,3,4-tetra-
AT360971B (de) Verfahren zur herstellung neuer alkinole
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
DD131169A5 (de) Verfahren zur herstellung neuer azatetracyclen
ATA111380A (de) Verfahren zur herstellung neuer basisch substituierter 0-(2-hydroxypropyl)-aldoxime
ATA111480A (de) Verfahren zur herstellung neuer basisch substi- tuierter 0-(2-hydroxypropyl)-aldoxime
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT348162B (de) Verfahren zur herstellung neuer d-homosteroide
AT355239B (de) Verfahren zur herstellung neuer d-homosteroide
ATA590279A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT351512B (de) Verfahren zur herstellung neuer substituierter fluoracylresorcine
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee